Towards the chemoenzymatic synthesis of heparan sulfate oligosaccharides: Oxidative cleavage of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

1. Advances in the preparation and synthesis of heparin and related products.Drug discovery today · 2020
   Review
2. Chemoenzymatic synthesis of unmodified heparin oligosaccharides: cleavage of p-nitrophenyl glucuronide by alkaline and Smith degradation.Organic & biomolecular chemistry · 2017
   Article
3. Glycoarray Technologies: Deciphering Interactions from Proteins to Live Cell Responses.Microarrays (Basel, Switzerland) · 2016
   Review
4. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?Molecules (Basel, Switzerland) · 2015
   Review
5. Chemoenzymatic synthesis of heparan sulfate and heparin.Natural product reports · 2014
   Review
6. Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides.Organic letters · 2014
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as